HC2’s MediBeacon secures Breakthrough Device status from FDA for TGFR
Oct 25, 2018 @ 14:27

HC2’s subsidiary MediBeacon has been granted Breakthrough Device designation from the US Food and Drug Administration (FDA) for its Transdermal GFR Measurement System (TGFR).

Sourced through Scoop.it from: www.compelo.com

Leave a Reply